What it's for (Indications)
- Hydrocortisone + miconazole cream is indicated for the topical treatment of inflammatory skin conditions where a fungal or candidal infection is present or suspected, and where the anti-inflammatory and antipruritic effects of a low-potency corticosteroid are desired.
- This combination therapy is particularly effective in addressing dermatomycoses, such as tinea pedis (athlete's foot), tinea cruris (jock itch), tinea corporis (ringworm), and candidiasis (e.
- g.
- , intertrigo, nappy rash where fungal infection is a factor), especially when these conditions are accompanied by significant inflammation, erythema, and pruritus.
- The hydrocortisone component reduces inflammation and associated symptoms like itching and redness, while miconazole nitrate effectively targets the fungal or yeast pathogen responsible for the infection.
- This dual-action approach aims to alleviate symptoms rapidly while eradicating the underlying fungal cause, thereby preventing symptom recurrence related to ongoing infection.
- It is crucial to confirm the presence of a fungal or candidal component for appropriate use.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The typical dosage regimen for hydrocortisone + miconazole cream involves applying a thin layer of the cream to the affected skin area twice daily, usually in the morning and evening. The cream should be gently rubbed into the skin until it is fully absorbed. Treatment duration should generally not exceed 7 to 14 days, particularly on sensitive areas such like the face, groin, or in pediatric patients, to minimize the risk of corticosteroid-related adverse effects. If no improvement is observed after 7 days, or if the condition worsens, re-evaluation by a healthcare professional is necessary to confirm the diagnosis and modify treatment if required. For fungal infections, it is often recommended to continue topical miconazole therapy (without the corticosteroid) for a period after the inflammatory symptoms have subsided to ensure complete eradication of the fungal pathogen. Occlusive dressings should not be used unless specifically instructed by a physician, as they can significantly increase systemic absorption of hydrocortisone and enhance local side effects. The amount applied should be the smallest effective quantity. |
Safety & Warnings
Common Side Effects
- As with any topical medication, hydrocortisone + miconazole cream can cause a range of side effects, although not everyone experiences them.
- Local adverse reactions are more common and are usually mild and transient.
- These may include skin irritation, burning, stinging, itching, erythema, or dryness at the application site.
- Hypersensitivity reactions, such as contact dermatitis, can occur, manifested by increased redness, itching, or swelling.
- Prolonged or extensive use, especially under occlusion or on areas with thin skin, can lead to more significant local effects associated with corticosteroids, such as skin atrophy (thinning), striae (stretch marks), telangiectasias (spider veins), acneiform eruptions, hypertrichosis (excessive hair growth), and perioral dermatitis.
- Depigmentation may also occur, particularly in individuals with darker skin tones.
- Systemic absorption of hydrocortisone, though less common with low-potency formulations, can lead to hypothalamic-pituitary-adrenal (HPA) axis suppression, Cushing's syndrome, hyperglycemia, and glucosuria, especially in children or with prolonged, extensive use.
- Miconazole can rarely cause local irritation.
- Patients should report any persistent or worsening side effects to their healthcare provider.
Serious Warnings
- Black Box Warning: Topical hydrocortisone, even at low potency, when combined with miconazole, does not typically carry an FDA-mandated Black Box Warning. However, it is imperative for healthcare professionals and patients to be aware of significant safety considerations, which warrant a 'Serious Warnings' section. Prolonged or extensive use, application to large surface areas, use under occlusive dressings, or use in pediatric patients can lead to systemic absorption of hydrocortisone. This systemic absorption carries risks including hypothalamic-pituitary-adrenal (HPA) axis suppression, manifestations of Cushing's syndrome, hyperglycemia, and glucosuria. In children, systemic absorption can also lead to growth retardation, delayed weight gain, and intracranial hypertension. Patients should be monitored for these effects, especially if applying to sensitive areas or for extended periods. Discontinuation should be gradual if HPA axis suppression is suspected. Avoid application to the face, groin, or axillae unless specifically directed by a healthcare provider, and avoid prolonged treatment duration to minimize potential systemic and local adverse effects. Misuse or overuse can exacerbate these risks significantly.
- Topical hydrocortisone + miconazole cream should be used with caution, and its application should be limited to the shortest possible duration and smallest effective area to mitigate potential risks.
- Special care is required when applying to the face, as prolonged use can lead to skin thinning, telangiectasias, and perioral dermatitis; use on the face should be strictly limited to a few days.
- The cream should not be applied to the eye or eyelids due to the risk of glaucoma and cataracts.
- In cases of significant systemic absorption, particularly in pediatric patients or with extensive and prolonged use, HPA axis suppression can occur, potentially leading to adrenal insufficiency upon abrupt discontinuation.
- Pediatric patients may be more susceptible to systemic toxicity due to a larger skin surface area to body weight ratio.
- If irritation or sensitization develops with the use of hydrocortisone + miconazole cream, treatment should be discontinued, and appropriate alternative therapy instituted.
- While miconazole has broad-spectrum antifungal activity, this combination is not effective against all fungal or bacterial pathogens; therefore, a definitive diagnosis is important.
- Concurrent use of occlusive dressings is generally not recommended as it increases systemic absorption and local adverse effects.
- Patients should be advised against self-treating for extended periods without medical supervision.
How it Works (Mechanism of Action)
Hydrocortisone + miconazole cream combines two active pharmaceutical ingredients, each with a distinct mechanism of action, to provide comprehensive treatment for inflammatory fungal skin conditions. Hydrocortisone, a low-potency corticosteroid, exerts its therapeutic effects primarily by its anti-inflammatory, antipruritic, and vasoconstrictive properties. It acts by inducing phospholipase A2 inhibitory proteins, collectively called lipocortins, which control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes. This inhibition leads to a reduction in the release of arachidonic acid, thereby suppressing the inflammatory cascade and alleviating symptoms like redness, swelling, and itching. Miconazole nitrate, an imidazole antifungal agent, acts by inhibiting the biosynthesis of ergosterol, a crucial component of the fungal cell membrane. This inhibition leads to structural and functional impairment of the fungal cytoplasmic membrane, increasing permeability, which ultimately results in leakage of essential intracellular components and fungal cell death. Miconazole also exhibits some antibacterial activity against certain Gram-positive bacteria, which can be beneficial in cases of secondary bacterial infection. The synergistic action of these two components allows for rapid symptom relief while actively eradicating the fungal pathogen.
Commercial Brands (Alternatives)
No other brands found for this formula.